Status:
UNKNOWN
Axial Involvement in Psoriatic Arthritis Cohort
Lead Sponsor:
Charite University, Berlin, Germany
Collaborating Sponsors:
Assessment of Spondyloarthritis International Society (ASAS)
Group for Research and Assessment of Psoriasis and Psoriatic Arthritis
Conditions:
Psoriatic Arthritis
Eligibility:
All Genders
Brief Summary
This is a multinational multicenter cross-sectional study in patients with a definite diagnosis of PsA. The population of interest will consist of 400 adult patients diagnosed with PsA and fulfilling ...
Detailed Description
Background. Involvement of the axial skeleton (of sacroiliac joints and / or spine) is one of the frequent manifestations associated with psoriatic skin disease along with involvement of peripheral mu...
Eligibility Criteria
Inclusion
- Age \>=18 years.
- Definite diagnosis of PsA.
- Fulfilment of the CASPAR criteria for PsA.
- Duration of PsA symptoms ≤10 years.
- Written informed consent.
Exclusion
- Unable or unwilling to give informed consent or to comply with the protocol.
- Current or past treatment with biologic or a targeted synthetic disease-modifying antirheumatic drug (DMARDs).
- Contraindications for MRI and/or plain X-ray examination of sacroiliac joints and spine.
Key Trial Info
Start Date :
July 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2023
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT04434885
Start Date
July 1 2021
End Date
December 1 2023
Last Update
June 27 2022
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Toronto Western Hospital
Toronto, Ontario, Canada, M5T 2S8
2
Charité - Universitätsmedizin Berlin
Berlin, Germany